Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Weatherald

Showing results (141-150 of 154) with videos related to

Pageof 16
Sort By:
Pulmonary Circulation|December 8, 2025
Transitioning From Parenteral Prostanoids to Oral Selexipag in Pulmonary Arterial Hypertension: A Multicenter Retrospective Cohort StudyBrandon Budhram, Sarah K Alrasheed, Moaaz Rashad, et al.
Acta Anaesthesiologica Scandinavica|January 24, 2023
Awake proning in patients with COVID-19-related hypoxemic acute respiratory failure: A rapid practice guidelineSheila Nainan Myatra, Waleed Alhazzani, Emilie Belley-Cote, et al.
BMJ (Clinical Research Ed.)|February 6, 2023
Efficacy of awake prone positioning in patients with covid-19 related hypoxemic respiratory failure: systematic review and meta-analysis of randomized trialsJason Weatherald, Ken Kuljit S Parhar, Zainab Al Duhailib, et al.
The Lancet. Respiratory Medicine|February 23, 2025
Future treatment paradigms in pulmonary arterial hypertension: a personal view from physicians, health authorities, and patientsFranck F Rahaghi, Marc Humbert, Marius M Hoeper, et al.
Annals of the American Thoracic Society|January 27, 2021
Association between Leflunomide and Pulmonary HypertensionThomas Lacoste-Palasset, Marie-Camille Chaumais, Jason Weatherald, et al.
American Journal of Respiratory and Critical Care Medicine|May 13, 2022
COVID-19 in Patients with Pulmonary Hypertension: A National Prospective Cohort StudyDavid Montani, Marie-Caroline Certain, Jason Weatherald, et al.
Pulmonary Circulation|December 25, 2023
Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working GroupKellie Morland, Christian Gerges, Jean Elwing, et al.
CMAJ Open|October 6, 2022
Cost-effectiveness of remdesivir plus usual care versus usual care alone for hospitalized patients with COVID-19: an economic evaluation as part of the Canadian Treatments for COVID-19 (CATCO) randomized clinical trialVincent I Lau, Robert Fowler, Ruxandra Pinto, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 5, 2025
International Society for Heart and Lung Transplantation (ISHLT) Consensus Statement on Risk Stratification in Pulmonary Arterial HypertensionSandeep Sahay, Scott Visovatti, Adriano R Tonelli, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 24, 2025
Authors' Perspective on the International Society for Heart and Lung Transplantation Consensus Statement on Risk Stratification in Pulmonary Arterial HypertensionSandeep Sahay, Scott Visovatti, Adriano R Tonelli, et al.
Pageof 16

Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
Pulmonary Circulation|December 8, 2025
Transitioning From Parenteral Prostanoids to Oral Selexipag in Pulmonary Arterial Hypertension: A Multicenter Retrospective Cohort StudyBrandon Budhram, Sarah K Alrasheed, Moaaz Rashad, et al.
Acta Anaesthesiologica Scandinavica|January 24, 2023
Awake proning in patients with COVID-19-related hypoxemic acute respiratory failure: A rapid practice guidelineSheila Nainan Myatra, Waleed Alhazzani, Emilie Belley-Cote, et al.
BMJ (Clinical Research Ed.)|February 6, 2023
Efficacy of awake prone positioning in patients with covid-19 related hypoxemic respiratory failure: systematic review and meta-analysis of randomized trialsJason Weatherald, Ken Kuljit S Parhar, Zainab Al Duhailib, et al.
The Lancet. Respiratory Medicine|February 23, 2025
Future treatment paradigms in pulmonary arterial hypertension: a personal view from physicians, health authorities, and patientsFranck F Rahaghi, Marc Humbert, Marius M Hoeper, et al.
Annals of the American Thoracic Society|January 27, 2021
Association between Leflunomide and Pulmonary HypertensionThomas Lacoste-Palasset, Marie-Camille Chaumais, Jason Weatherald, et al.
American Journal of Respiratory and Critical Care Medicine|May 13, 2022
COVID-19 in Patients with Pulmonary Hypertension: A National Prospective Cohort StudyDavid Montani, Marie-Caroline Certain, Jason Weatherald, et al.
Pulmonary Circulation|December 25, 2023
Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working GroupKellie Morland, Christian Gerges, Jean Elwing, et al.
CMAJ Open|October 6, 2022
Cost-effectiveness of remdesivir plus usual care versus usual care alone for hospitalized patients with COVID-19: an economic evaluation as part of the Canadian Treatments for COVID-19 (CATCO) randomized clinical trialVincent I Lau, Robert Fowler, Ruxandra Pinto, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 5, 2025
International Society for Heart and Lung Transplantation (ISHLT) Consensus Statement on Risk Stratification in Pulmonary Arterial HypertensionSandeep Sahay, Scott Visovatti, Adriano R Tonelli, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 24, 2025
Authors' Perspective on the International Society for Heart and Lung Transplantation Consensus Statement on Risk Stratification in Pulmonary Arterial HypertensionSandeep Sahay, Scott Visovatti, Adriano R Tonelli, et al.
Pageof 16